What is the revenue of AbbVie?
45.8 billion USD (Fiscal Year Ended December 31, 2020)
AbbVie/Revenue
How much of AbbVie revenue is Humira?
Financial Release
| AbbVie Inc. Key Product Revenues Quarter Ended March 31, 2021 (Unaudited) | ||
|---|---|---|
| ADJUSTED NET REVENUESc | $9,675 | 50.1% |
| Immunology | 4,633 | 12.9 |
| Humira | 3,907 | 3.5 |
| Skyrizi | 481 | 91.1 |
How does AbbVie make money?
AbbVie’s key product revenues 2019-2020 AbbVie is an international pharmaceutical company with a multitude of pharmaceutical products available. In 2020, the company’s top revenue generating drug was Humira. During that year Humira generated about 19.8 billion U.S. dollars in revenue for AbbVie.
What time does ABBV release earnings?
NORTH CHICAGO, Ill. , July 7, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .
Who is the CEO of AbbVie?
Richard A. Gonzalez (Jan 2, 2013–)
AbbVie/CEO
WASHINGTON — AbbVie CEO Richard Gonzalez is in for a congressional tongue-lashing of outsized proportion. And it couldn’t come at a worse time. Just two years ago, AbbVie seemed on the verge of serious financial trouble.
How much does an AbbVie sales rep make?
Average AbbVie Pharmaceutical Sales Representative yearly pay in the United States is approximately $102,374, which is 52% above the national average.
Who is AbbVie owned by?
Abbott Laboratories
AbbVie is a research-based biopharmaceutical company. It spun off of Abbott Laboratories in 2013. The company has had a successful start in its first five years in the industry.
What drugs does AbbVie sell?
AbbVie
| Type | Public |
|---|---|
| Products | Pharmaceutical drugs Humira (adalimumab) Imbruvica (ibrutinib) Venclexta (venetoclax) Zinbryta (daclizumab) Kaletra (lopinavir) Norvir (ritonavir) Mavyret/Maviret (glecaprevir/pibrentasvir) Skyrizi (risankizumab) |
| Revenue | US$45.804 Billion (Fiscal Year Ended December 31, 2020) |
Is AbbVie a good company to work for?
When it comes to the biotech and pharmaceuticals industry, Illinois-based AbbVie is the best place to work, according to a new survey. AbbVie achieved an overall 90 percent ranking in employee satisfaction, with 96 percent of employees stating they feel good about the way the company contributes to the community.
Is Allergan part of AbbVie?
NORTH CHICAGO, Ill., May 8, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by …
Will AbbVie beat earnings?
We expect AbbVie ABBV to beat expectations when it reports second-quarter 2021 results on Jul 30, before market open. In the last reported quarter, the company delivered an earnings surprise of 6.50%. The large drugmaker’s performance has been pretty impressive, with earnings beat in each of the trailing four quarters.
Who owns AbbVie?
key takeaways. Pharmaceutical company AbbVie, spun off by Abbott Laboratories in 2012, is now larger than its erstwhile parent.
Where can I find the financial reports of AbbVie?
View a full library of AbbVie’s financial new releases. Access all of AbbVie’s SEC filings. View AbbVie’s annual reports on Form 10-K and proxy statements.
When did AbbVie become a separate company from Abbott?
Please try again later. AbbVie may have been founded in 2013, but our roots run deep. In 2013, we became a separate company from Abbott, though we share a common legacy and strong prospects for future success. Our name represents our connection to the past and the future.
What makes AbbVie a good company to work for?
If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day. That’s what drives me. It’s the greater impact we can have by working here at AbbVie. AbbVie ranked No. 5 on DiversityInc’s list for 2020.
When does the AbbVie dividend go into effect?
NORTH CHICAGO, Ill. , June 17, 2021 /PRNewswire/ — The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share. The cash dividend is payable August 16, 2021 to stockholders of record at the close of business on July 15, 2021 .